Neural antigen-specific autoimmune disorders.

Area of Science:

• Neuroimmunology
• Neurology
• Autoimmunity

Background:

• Neural-specific autoantibodies are implicated in a spectrum of neurological disorders.
• These disorders can be idiopathic or paraneoplastic, affecting various nervous system components.
• Molecular identification of autoantigens has improved diagnostic test development.

Purpose of the Study:

• To review the immunobiology, pathophysiology, and clinical spectrum of autoimmune neurological disorders.
• To differentiate disorders based on autoantibody target location (intracellular vs. plasma membrane).
• To highlight the diagnostic and therapeutic implications of autoantibody classification.

Main Methods:

• Review of existing literature on neural-specific autoantibodies.
• Classification of autoantibodies based on antigen location (intracellular or plasma membrane).
• Analysis of immunohistopathological findings and treatment responses.

Main Results:

• Autoantibodies recognizing intracellular antigens are associated with T-cell mediated disorders, showing limited response to antibody-depleting therapies.
• Autoantibodies targeting plasma membrane antigens have pathogenic potential and are often responsive to immunotherapy.
• Disorders with plasma membrane autoantibodies are frequently misdiagnosed as neurodegenerative.

Conclusions:

• Classification of autoimmune neurological disorders by autoantibody target location is crucial for diagnosis and prognosis.
• Plasma membrane autoantibody-associated disorders are potentially reversible with immunotherapy.
• Distinguishing these from neurodegenerative conditions is vital for appropriate patient management.